Sélectionner une page

Decode ultrasound data to achieve unparalleled diagnostic performances

Our first goal is to bring non-invasive neuromonitoring closer to patient’s needs.

01

MRI & CT scans lead the digital transition

But their availability for many patients remains limited by high hardware and infrastructure costs.

02

Ultrasounds are accessible & safe

But their potential remains vastly under exploited with just 10% of the data being processed.

What if we could decode 100 % of the raw ultrasound data?

Resolve diagnostics

Our aim is to speed up care from emergency to complete patient recovery.

First responders

Emergencies

Images studies

Guided interventions

Bedside monitoring

Rehabilitation

OUR AMBITION

Build a biomarker engine

To widen the access to diagnostic and solve unmet medical needs.

OUR FIRST FOCUS

Neuromonitoring

Provide non-invasive monitoring of the cerebral blood flows in neurocritical care.

Build tools to help physicians reach informed decisions

The first application of our engine will be made available in SYLVER*, an autonomous ultrasound scanner designed for neurocritical care.

01

Accessible

Non-invasive, safe, compact, and user-friendly, no advanced expertise needed.

02

Reliable quantitive insights

Access to new markers for monitoring the cerebral blood flows and perfusion.

*In development, not available for sale.

Bring change to all stakeholders

    • Advance toward a more personalized treatment for critically ill patients.
    • Drive growth & improve productivity of neurocritical care departments.
    • Participate in overall cost reduction with strong medico-economic benefits.

Lead the digital transition in ultrasounds & unlock access to brain imaging

today

Reveal the full potential of data-driven ultrasound to help shape a brighter future

tomorrow

Creating change together

Latest news

Resolve stroke at RSNA

LinkedIn, Nov. 2023

Exciting time in Chicago attending the Radiological Society of North America (RSNA) 2023 meeting.It has been a busy and energising 4 days, engaging with partners, industry leaders and KOLs.

View more

Resolve stroke, la medtech qui facilite le diagnostic de l'AVC

Les Echos, Sept. 18 2023

La start-up, issue du spin-off d’un laboratoire, vient de réaliser sa première levée de fonds de 2,2 millions d’euros. Elle va lancer ses essais cliniques avec le CHU de Caen à la fin de l’année.

View more

Resolve stroke remporte le prix innovation JFR 2023

LinkedIn, Oct. 2023

Resolve Stroke a remporté le premier Prix Innovation dans la catégorie Start-up aux JFR 2023 décerné par la Société Française de Radiologie et d’imagerie médicale (SFR)…

View more

How Paris is becoming a happy home for health-technology start-up companies

Nature, Nov. 08 2023

A long-term investment plan is helping the French capital to attract talent.

View more

La start-up française « Resolve Stroke » sélectionnée parmi les finalistes du Prix Spinoff 2023

Springer Nature, June.16 2023

Resolve Stroke, une start-up française […] a été sélectionnée parmi les cinq finalistes pour le prix Spinoff de cette année.

View more

Revealing vascular roadblocks in the brain

Nature, May. 24 2023

High-resolution imaging quickly identifies blood clots before they inflict major damage. Resolve Stroke in Paris spin off from Sorbonne University….

View more